IRIX Iridex Corp
- Stocks
- Healthcare
- NASDAQ: IRIX
Price (delayed)
$1.39
Market cap
$23.34M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.43
Enterprise value
$21.39M
Iridex Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company's proprietary MicroPulse®
Highlights
The quick ratio has surged by 71% since the previous quarter and by 22% year-on-year
The EPS has increased by 36% YoY and by 20% QoQ
Iridex's debt has soared by 110% YoY and by 14% from the previous quarter
IRIX's equity has dropped by 87% year-on-year and by 59% since the previous quarter
Key stats
What are the main financial stats of IRIX
Market
Valuations
Earnings
Shares outstanding
16.79M
Market cap
$23.34M
Enterprise value
$21.39M
Price to earnings (P/E)
N/A
Price to book (P/B)
27.39
Price to sales (P/S)
0.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.44
Revenue
$48.8M
Gross profit
$20.1M
Operating income
-$5.22M
Net income
-$7.13M
EBIT
-$7.09M
EBITDA
-$5.69M
Free cash flow
-$6.81M
Per share
Balance sheet
Liquidity
EPS
-$0.43
EPS diluted
-$0.43
Free cash flow per share
-$0.41
Book value per share
$0.05
Revenue per share
$2.92
TBVPS
$1.92
Total assets
$34.24M
Total liabilities
$27.38M
Debt
$5.3M
Equity
$852,000
Working capital
$14.18M
Debt to equity
6.22
Current ratio
1.95
Quick ratio
1.11
Net debt/EBITDA
0.34
Margins
Efficiency
Dividend
EBITDA margin
-11.7%
Gross margin
41.2%
Net margin
-14.6%
Operating margin
-10.7%
Return on assets
-22.9%
Return on equity
-290.6%
Return on invested capital
-55%
Return on capital employed
-36.8%
Return on sales
-14.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IRIX stock price
How has the Iridex stock price performed over time
Intraday
-0.71%
1 week
-1.07%
1 month
57.61%
1 year
-28.72%
YTD
-17.26%
QTD
57.61%
Financial performance
How have Iridex's revenue and profit performed over time
Revenue
$48.8M
Gross profit
$20.1M
Operating income
-$5.22M
Net income
-$7.13M
Gross margin
41.2%
Net margin
-14.6%
IRIX's operating income has surged by 52% year-on-year and by 37% since the previous quarter
The operating margin has surged by 51% year-on-year and by 37% since the previous quarter
The net income is up by 35% YoY and by 20% QoQ
Iridex's net margin has increased by 33% YoY and by 20% from the previous quarter
Price vs fundamentals
How does IRIX's price correlate with its fundamentals
Growth
What is Iridex's growth rate over time
Valuation
What is Iridex stock price valuation
P/E
N/A
P/B
27.39
P/S
0.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.44
The EPS has increased by 36% YoY and by 20% QoQ
The price to book (P/B) is 109% higher than the last 4 quarters average of 13.1
IRIX's equity has dropped by 87% year-on-year and by 59% since the previous quarter
The stock's price to sales (P/S) is 56% less than its 5-year quarterly average of 1.1 and 20% less than its last 4 quarters average of 0.6
The revenue has declined by 2.2% year-on-year
Efficiency
How efficient is Iridex business performance
Iridex's ROE has plunged by 176% YoY and by 26% from the previous quarter
The ROS has increased by 33% YoY and by 20% QoQ
IRIX's return on invested capital is up by 27% year-on-year and by 24% since the previous quarter
The company's return on assets rose by 27% YoY and by 20% QoQ
Dividends
What is IRIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IRIX.
Financial health
How did Iridex financials performed over time
Iridex's total assets is 25% higher than its total liabilities
The quick ratio has surged by 71% since the previous quarter and by 22% year-on-year
The company's current ratio rose by 37% QoQ and by 13% YoY
Iridex's debt to equity has surged by 181% QoQ
Iridex's debt has soared by 110% YoY and by 14% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.